The National Alliance of State and Territorial AIDS Directors (NASTAD) is a 501(c)(3) nonprofit organization headquartered in Washington, DC. Founded in 1992 and tax-exempt since November 1993, NASTAD represents public health officials who administer HIV and hepatitis programs across the United States and internationally. The organization strengthens governmental public health through advocacy, capacity building, and social justice initiatives focused on advancing the health and dignity of people living with and impacted by HIV/AIDS, viral hepatitis, and intersecting epidemics.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$15.8M
+20.4% YoY
Annual Giving
$8.9M
-3.5% YoY
Grant Count
97
+16.9% YoY
Avg Grant Size
$92K
-17.5% YoY
Mission & Focus Areas
NASTAD's vision is a world committed to ending HIV/AIDS, viral hepatitis, and intersecting epidemics. The organization operates through seven programmatic teams:
- Health Care Access
- Health Systems Integration
- Policy & Legislative Affairs
- Hepatitis
- Prevention
- Health Equity
- Drug User Health
These teams interpret and influence policies, conduct trainings, offer technical assistance, and provide advocacy mobilization for U.S. health departments to improve health outcomes for people living with HIV and hepatitis.
Primary focus areas include:
- HIV Prevention and Surveillance: Capacity building and technical assistance activities in support of state and local HIV prevention programs, including the Ending the HIV Epidemic (EHE) initiative
- Viral Hepatitis: Technical assistance and capacity building for hepatitis prevention and treatment, including support for hepatitis A, B, and C vaccines
- Harm Reduction: Partnership with the CDC's Division of Viral Hepatitis for the National Harm Reduction Technical Assistance Center, supporting syringe services programs and other harm reduction providers
- Syndemic Approaches: Prevention activities addressing intersecting epidemics
- Technical Assistance Centers: Operation of the HIV Prevention and Surveillance Technical Assistance Center (Heptac) and the National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers (Hepnet)
Grantmaking
NASTAD functions primarily as a grantee and technical assistance provider rather than a traditional grantmaker. However, the organization distributes funding to support state and local health departments.
Ready to take the next step with National Alliance of State and?
Geographic Focus
Where this funder awards grants
NASTAD operates in the United States and internationally, with operations in eight countries including South Africa, Botswana, Zambia, Trinidad and Tobago, and Jamaica. Primary domestic funding focus areas include Washington, DC and Tennessee.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
Most Recent Financial Data (2024):
- Total revenues: $25,053,040
- Total expenses: $23,721,187
- Total assets: $15,845,205
- Employees: 72
Previous Year Data (2023):
- Revenue: $26.5M
- Expenses: $26M
- Total assets: $13.2M
- Total liabilities: $8.64M
Rating:
NASTAD holds an 88% score, earning a Three-Star rating based on Accountability & Finance metrics.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $15,845,205 | $13,162,788 | $12,367,221 |
| Revenue | $25,053,040 | $26,523,136 | $18,000,771 |
| Expenses | $23,721,187 | $25,983,603 | $17,011,945 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $1,423 | $1,512 | $642 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
162 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
Key executives include:
- Tim Horn: Director, Health Care Access
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| CLOVER BARNES | CHAIR (FROM 6/2024) | 1.5 | — |
| SARAH BRAUNSTEIN | CHAIR-ELECT (FROM 6/2024) | 1.5 | — |
| DAVID KERN | IMMEDIATE PAST CHAIR (FROM 6/2024) | 1.5 | — |
| ELIZABETH CRUTSINGER-PERRY | IMMEDIATE PAST CHAIR (UNTIL 5/2024) | 1.5 | — |
| MARIA JACKSON | VICE CHAIR (FROM 6/2024) | 1.5 | — |
| TOM DUNN | TREASURER (FROM 6/2024) | 1.5 | — |
| JEREMY TURNER | TREASURER (UNTIL 5/2024) | 1.5 | — |
| DEBRA GUILBAULT | SECRETARY | 1.5 | — |
| VINCE AGUON | DIRECTOR (UNTIL 5/2024) | 1 | — |
| KATHLEEN BRADY | DIRECTOR | 1 | — |
| LARISA BRUNER | DIRECTOR | 1 | — |
| SAMUEL BURGESS | DIRECTOR | 1 | — |
| BARRY CALLIS | DIRECTOR (FROM 6/2024) | 1 | — |
| ANDY DILLEHAY | DIRECTOR | 1 | — |
| CHELSEA FRAND | DIRECTOR (FROM 6/2024) | 1 | — |
| DAWN FUKUDA | DIRECTOR (UNTIL 5/2024) | 1 | — |
| ANTHONY HANNAH | DIRECTOR | 1 | — |
| PHADRE JOHNSON | DIRECTOR (FROM 6/2024) | 1 | — |
| CHRISTINE JONES | DIRECTOR | 1 | — |
| JIMMY LLAQUE | DIRECTOR (FROM 6/2024) | 1 | — |
| JOYCE MBUGUA | DIRECTOR (FROM 6/2024) | 1 | — |
| FELENCIA MCGEE | DIRECTOR | 1 | — |
| VONTRESE MCGHEE | DIRECTOR (UNTIL 5/2024) | 1 | — |
| LORLETTE MOIR | DIRECTOR | 1 | — |
| ANDREA PEREZ | DIRECTOR | 1 | — |
| THADDEUS PHAM | DIRECTOR | 1 | — |
| MARISA RAMOS | DIRECTOR | 1 | — |
| DENNIS RIVERA | DIRECTOR | 1 | — |
| SCOTT STOKES | DIRECTOR | 1 | — |
| KIMBERLY TRUSS | DIRECTOR (UNTIL 5/2024) | 1 | — |
| STEPHEN LEE | EXECUTIVE DIRECTOR | 40 | $245,801 |
| NATALIE CRAMER | DEPUTY EXECUTIVE DIRECTOR, PROGRAM | 40 | $174,591 |
| VIRGINIE CAREY | DEPUTY EXECUTIVE DIRECTOR, OPERATIONS | 40 | $179,426 |
| AUNTRE HAMP | SR. DIR., PUBLIC HEALTH SYSTEMS | 40 | $150,976 |
| TIM HORN | DIRECTOR, MEDICATION ACCESS | 40 | $134,290 |
| ISAIAH WEBSTER III | SR. DIR., ORGANIZATIONAL EXCELLENCE | 40 | $146,344 |
| EMILY SCHREIBER | SR. DIR., POLICY & LEG. AFFAIRS | 40 | $141,948 |
| BOATEMAA NTIRI REID | SR. DIR., SYNDEMIC APPROACHES | 40 | $131,607 |
Recent News & Activity
Recent developments and announcements
NASTAD has received significant federal funding to support state and local HIV prevention efforts:
HHS Awards $13.5 Million to Accelerate State and Local Planning ...**Ending the HIV Epidemic (EHE) Initiative**: NASTAD received CDC funding through a cooperative agreement to conduct capacity building and technical assistance activities in support of state and local HIV prevention programs funded for Phase 1 of the EHE initiative.
HHS Awards $13.5 Million to Accelerate State and Local Planning ...**HIV Cluster Detection and Response**: NASTAD received CDC funding through CSTLTS to develop a learning community regarding HIV cluster detection and response.
**EHE Phase I Expansion**: On September 30, 2022, NASTAD received supplemental funding from CDC's Division of Health Promotion to expand EHE Phase I implementation activities.
**HIV Self-Testing Project**: On September 30, 2022, NASTAD was funded through a five-year subaward from Emory University for a CDC National HIV self-testing project called "Together Take Me Home."
Subject Areas
Focus areas based on grantmaking activity
Related Funders
Similar funders by location and focus area
Demand Justice Initiative
WASHINGTON, DC
Assets
$7.6M
Grants
1
Total Given
$225K
American Academic Leadership Institute
WASHINGTON, DC
Assets
$3.6M
Grants
2
Total Given
$50K
Cnfa
WASHINGTON, DC
Assets
$18.3M
Grants
9
Total Given
$4.2M
Partnership for a Healthier America
WASHINGTON, DC
Assets
$10.8M
Grants
12
Total Given
$350K
Association of Schools of Allied Health
WASHINGTON, DC
Assets
$2.3M
Grants
2
Total Given
$60K
Fulcrum Foundation Inc
WASHINGTON, DC
Assets
$53K
Grants
10
Total Given
$13K
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with National Alliance of State and on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities